^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Hodgkin Lymphoma
    Drug:carboplatin (Tubulin polymerization promoter) +
    etoposide oral (Topoisomerase II inhibitor, DNA inhibitor) +
    bendamustine (DNA replication inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Hodgkin lymphoma: Subsequent options…Bendamustine + carboplatin + etoposide